KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Current Deferred Revenue (2020 - 2025)

Oscar Health (OSCR) has disclosed Current Deferred Revenue for 6 consecutive years, with $77.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Deferred Revenue rose 16.62% year-over-year to $77.1 million, compared with a TTM value of $77.1 million through Sep 2025, up 16.62%, and an annual FY2024 reading of $74.4 million, up 12.85% over the prior year.
  • Current Deferred Revenue was $77.1 million for Q3 2025 at Oscar Health, up from $69.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $79.0 million in Q4 2022 and bottomed at $56.2 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $70.3 million, with a median of $71.9 million recorded in 2021.
  • The sharpest move saw Current Deferred Revenue surged 33.75% in 2022, then decreased 17.93% in 2024.
  • Year by year, Current Deferred Revenue stood at $75.0 million in 2021, then grew by 5.27% to $79.0 million in 2022, then decreased by 16.56% to $65.9 million in 2023, then increased by 12.85% to $74.4 million in 2024, then increased by 3.67% to $77.1 million in 2025.
  • Business Quant data shows Current Deferred Revenue for OSCR at $77.1 million in Q3 2025, $69.5 million in Q2 2025, and $70.9 million in Q1 2025.